Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.
about
Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndromeCardiac and skeletal muscle defects in a mouse model of human Barth syndromeCharacterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiencyShotgun lipidomics reveals the temporally dependent, highly diversified cardiolipin profile in the mammalian brain: temporally coordinated postnatal diversification of cardiolipin molecular species with neuronal remodelingFormation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid speciesThe cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndromeShotgun lipidomics of cardiolipin molecular species in lipid extracts of biological samplesAlterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics studyLipid Acyl Chain Remodeling in YeastThe Role of Cardiolipin in Cardiovascular HealthPower(2): the power of yeast genetics applied to the powerhouse of the cellCardiolipin and its different properties in mitophagy and apoptosisMetabolism and regulation of glycerolipids in the yeast Saccharomyces cerevisiaeFunctional expression and characterization of five wax ester synthases in Saccharomyces cerevisiae and their utility for biodiesel productionThe translocator maintenance protein Tam41 is required for mitochondrial cardiolipin biosynthesis.Yeast Pgc1p (YPL206c) controls the amount of phosphatidylglycerol via a phospholipase C-type degradation mechanismMitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzinsUps1p and Ups2p antagonistically regulate cardiolipin metabolism in mitochondria.Cardiolipin mediates cross-talk between mitochondria and the vacuole.A mitochondrial phosphatase required for cardiolipin biosynthesis: the PGP phosphatase Gep4.Deacylation on the matrix side of the mitochondrial inner membrane regulates cardiolipin remodeling.Tam41 is a CDP-diacylglycerol synthase required for cardiolipin biosynthesis in mitochondria.Identification of a cardiolipin-specific phospholipase encoded by the gene CLD1 (YGR110W) in yeastTaz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth SyndromeYpr140wp, 'the yeast tafazzin', displays a mitochondrial lysophosphatidylcholine (lyso-PC) acyltransferase activity related to triacylglycerol and mitochondrial lipid synthesisAim24 and MICOS modulate respiratory function, tafazzin-related cardiolipin modification and mitochondrial architectureMisregulation of a DDHD Domain-containing Lipase Causes Mitochondrial Dysfunction in YeastMechanism for Remodeling of the Acyl Chain Composition of Cardiolipin Catalyzed by Saccharomyces cerevisiae TafazzinStructural and mechanistic insights into phospholipid transfer by Ups1-Mdm35 in mitochondriaMonolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosisThe enzymatic function of tafazzinComplex expression pattern of the Barth syndrome gene product tafazzin in human cell lines and murine tissuesLPS impairs oxygen utilization in epithelia by triggering degradation of the mitochondrial enzyme Alcat1Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genesCellular functions of cardiolipin in yeastCardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and functionThe topology and regulation of cardiolipin biosynthesis and remodeling in yeastBacteria, yeast, worms, and flies: exploiting simple model organisms to investigate human mitochondrial diseasesKnown unknowns of cardiolipin signaling: the best is yet to comeElimination of the unnecessary: intra- and extracellular signaling by anionic phospholipids
P2860
Q24320205-9308C81D-7E5B-4D4E-9C90-51B856DBF912Q24598420-09C7E566-7598-41E0-8110-3FA035F021A9Q24604918-93537430-510E-46D8-9E1B-40652777A2F8Q24645695-9BC4CB29-5330-4A3E-A9E6-72E494D73426Q24647646-3C75E56F-6A01-4EBB-9B41-50FB8EE88C0AQ24651872-C58FC513-7FE1-4871-8F30-EA328DB578D5Q24671079-0EABF6F7-795B-4C92-AFF0-F776CD922197Q24678475-2F4455AC-301B-4B0B-9E3D-B2B6DE65B1FFQ26773169-77820E41-5F98-4727-91B1-EB996D4C7FBBQ26798052-1CBED78D-7344-4A92-A986-61512AA47AE7Q27005796-7ABAF68D-8740-4116-BE93-7351DC29CEFBQ27024440-4FB9FDE0-F33E-4842-84A9-33FCE38B8F3CQ27027569-07E492B5-EB20-4F8D-B42B-057F67A81E95Q27499119-E8FE9BAB-2FBB-453D-A477-74FB6F265C64Q27929808-C841FD07-0652-4733-AB0E-3F78A734A5C7Q27930234-DF9C4D2E-A4A5-4271-97B4-5F895899B936Q27930348-FF62DB49-021C-42EB-8564-CF433DEB1CD3Q27930903-E438EA7B-12DC-4221-9063-69FD0635AD0AQ27931149-191E2261-9425-4B24-ACED-2429009E82E8Q27932633-FF4C292C-9B3A-4F49-A89E-453DBEB8F0EAQ27932861-F8DBD99D-27F8-4641-9451-CD0C7BAE8A1FQ27934246-6618EF1A-1AC8-4A19-9A7D-796A68115FE1Q27934941-922ECAC6-2CA3-4B40-B2C4-C921311B9070Q27936928-B1284522-F4AC-4764-913F-1BFD12EC1E55Q27938893-CBCE9E0C-2D97-4D7E-9A31-87B492CCE4F0Q27938907-85D4876A-3A46-4F58-867B-FB02CEF01044Q27939229-0EA6F9BE-F1D1-4D85-A0E2-3A6A2362AA3BQ27939541-76ADF4AB-ADF3-48F6-B9BF-27368F4FB84EQ27940332-2C629E07-9396-4691-BC04-981AEC3749DEQ28243113-228B3888-21AA-4BD4-9767-4A10EFBB3AA7Q28272001-71B48D0D-260E-44F6-A90F-D9E2F5951913Q28289152-6A8C02B8-D1B7-44A0-9538-93D1EF2B6150Q28385337-BDEED33C-E55E-49A2-9CE0-FF850C4DC2EFQ28387241-E8AC6EE5-E312-446B-BA0F-077B7F2958CEQ28392417-EED0F950-A830-48E1-BF05-D0A3C3C8609BQ28395178-45E73661-8BEE-4E90-8458-BC1FC514FF25Q28397368-190CB937-3574-4736-B045-5203DB2CCA2EQ28708978-7FCE372A-6C5B-4945-ADCE-B4D31ADE2947Q28917160-409F95CB-E4BD-425F-A966-EF9B0D12D734Q28917161-B6E6E0D0-F498-4C38-A717-034CACE44FE4
P2860
Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.
@ast
Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.
@en
Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.
@nl
type
label
Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.
@ast
Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.
@en
Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.
@nl
prefLabel
Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.
@ast
Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.
@en
Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.
@nl
P2093
P2860
P3181
P1476
Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome
@en
P2093
Frederic M Vaz
Fredoen Valianpour
Gertjan A Hakkaart
Miriam L Greenberg
Zhiming Gu
P2860
P304
P3181
P356
10.1046/J.1365-2958.2003.03802.X
P407
P577
2004-01-01T00:00:00Z